Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)

Market Cap	4.26B -9.1%
Revenue (ttm)	409.48M -22.2%
Net Income	28.99M -81.4%
EPS	0.23 -81.5%
Shares Out	127.08M
PE Ratio	147.19
Forward PE	n/a
Dividend	0.80 (2.30%)
Ex-Dividend Date	n/a

Volume	471,799
Open	34.98
Previous Close	34.75
Day's Range	33.22 - 34.98
52-Week Range	33.49 - 45.00
Beta	0.56
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Assure Tech (Hangzhou)

Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China. It is also involved in POCT and plastic product manufacturing; online sales; pharmaceutical sales; and medical testing. In addition, the company offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veterinary tests, as well as Biochemistry, chronic disease monitoring systems, and reader and analyzers. Further, it offers infectious disease, fertility, fe...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 720
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688075

Financial Performance

In 2025, Assure Tech (Hangzhou)'s revenue was 451.26 million, a decrease of -16.54% compared to the previous year's 540.70 million. Earnings were 69.42 million, a decrease of -63.90%.